Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalytic Crystallization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103025715A reveals a scalable route for Dabigatran intermediates using inorganic base hydrogenation, offering significant cost reduction in pharmaceutical manufacturing.
Patent CN101481318A details a catalytic hydrogenation route for electronic grade 2,2-bis[(3-amino-4-hydroxy)phenyl]-hexafluoropropane, offering low metal ion content and scalable manufacturing.
Patent CN87101834A details surfactant catalyzed crystallization. Reduces solvent use and improves yield for reliable hemin supply chains.
Advanced patent-based separation technology ensures high purity diamino naphthalene intermediates with optimized supply chain efficiency and cost reduction.
Patent CN1447800A reveals a catalytic SO2 process for thiamethoxam intermediates, offering safer scale-up and cost reduction in insecticide manufacturing.
Patent CN102531925A reveals a clean catalytic hydrogenation route for 1-aminoanthraquinone, offering >99% purity and eliminating toxic sulfur waste for cost-effective dye intermediate manufacturing.
Patent CN112645854B details a novel purification method for Apremilast intermediates using PEG-modified catalysts and specific solvent systems to achieve over 99.5% purity.
Advanced patent-based synthesis of Sarpogrelate Hydrochloride eliminating chromatography. Cost-effective manufacturing and high-purity supply chain solutions for global pharma.
Novel hydrogenation process for tebipenem achieves over 99.9 percent purity with water recrystallization, offering significant cost reduction in API manufacturing.
Patent CN112457307B details a biocatalytic extraction process achieving 100% optical purity. This method offers significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing.